# Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

> **NCT06118749** · — · TERMINATED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 72 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DIAGNOSTIC_TEST:** Antigen detection Rapid Diagnostic Test prototype

## Key facts

- **NCT ID:** NCT06118749
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-20
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Desk review conducted on study documentation revealing certain inconsistencies leading to the recommendation to halt the study.
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118749, "Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06118749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*